Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The promising novel therapies for familial hypercholesterolemia
Ruoyu Chen, Shaoyi Lin, Xiaomin Chen
Journal of Clinical Laboratory Analysis (2022) Vol. 36, Iss. 7
Open Access | Times Cited: 18

Showing 18 citing articles:

Management of Statin Intolerant Patients in the Era of Novel Lipid Lowering Therapies: A Critical Approach in Clinical Practice
Giosiana Bosco, Francesco Barbagallo, Salvatore Spampinato, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 6, pp. 2444-2444
Open Access | Times Cited: 18
Advances in Treatment of Dyslipidemia
Jill Dybiec, Wiktoria Baran, Bartłomiej Dąbek, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 17, pp. 13288-13288
Open Access | Times Cited: 18
State of Gene Therapy for Monogenic Cardiovascular Diseases
Sahej Bains, John R. Giudicessi, Katja E. Odening, et al.
Mayo Clinic Proceedings (2024) Vol. 99, Iss. 4, pp. 610-629
Open Access | Times Cited: 4
Harnessing RNA therapeutics: novel approaches and emerging strategies for cardiovascular disease management
Wang Dui, Zhao Xiao-bin, Zhang Haifeng, et al.
Frontiers in Cardiovascular Medicine (2025) Vol. 12
Open Access
Recent advances in regulating lipid metabolism to prevent coronary heart disease
Jingchun Du, Wei Wu, Boran Zhu, et al.
Chemistry and Physics of Lipids (2023) Vol. 255, pp. 105325-105325
Closed Access | Times Cited: 9
Rare variants in long non-coding RNAs are associated with blood lipid levels in the TOPMed whole-genome sequencing study
Yuxuan Wang, Margaret Sunitha Selvaraj, Xihao Li, et al.
The American Journal of Human Genetics (2023) Vol. 110, Iss. 10, pp. 1704-1717
Open Access | Times Cited: 8
Small interfering RNA (siRNA)-based therapeutics
Jacoby Patterson
Drug and Therapeutics Bulletin (2023) Vol. 61, Iss. 5, pp. 72-76
Closed Access | Times Cited: 6
Familial Hypercholesterolemia: A Literature Review of the Pathophysiology and Current and Novel Treatments
Yasha N Suryawanshi, Rupesh A Warbhe
Cureus (2023)
Open Access | Times Cited: 6
Enasidenib‐induced hepatitis in an individual with Type II D2‐hydroxyglutaric aciduria
Jessica I. Gold, Arianna K. Stefanatos, Jamie L. Fraser, et al.
JIMD Reports (2024) Vol. 65, Iss. 3, pp. 156-162
Open Access | Times Cited: 1
In vitro assessment of the pathogenicity of the LDLR c.2160delC variant in familial hypercholesterolemia
Shaoyi Lin, Tingting Hu, Kaihan Wang, et al.
Lipids in Health and Disease (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 2
Management of Familial Hypercholesterolemia with Special Emphasis on Evinacumab
Julia Krzemińska, Ewelina Młynarska, Ewa Radzioch, et al.
Biomedicines (2022) Vol. 10, Iss. 12, pp. 3273-3273
Open Access | Times Cited: 3
RNA therapeutics for metabolic disorders
Thuy-Duong Vu, Sheng‐Che Lin, Chia-Ching Wu, et al.
Progress in molecular biology and translational science (2024), pp. 181-196
Closed Access
Abordagens terapêuticas nas dislipidemias - com ênfase na ldl-c (aterogênica)
Thaís de Rezende Bessa Guerra, Andreia de Carvalho Lima Soares, Bianka Maria Salviano, et al.
Brazilian Journal of Health Review (2023) Vol. 6, Iss. 2, pp. 8063-8077
Open Access | Times Cited: 1
Assessment of the global and national market for lipid modifying agents: retrospective and innovation
Alena V. Lokhmacheva, С. Г. Фоминых, L. V. Trubina, et al.
Сибирский научный медицинский журнал (2023) Vol. 43, Iss. 4, pp. 23-43
Open Access | Times Cited: 1
The application of antisense oligonucleotides in disease treatment
Lokkwan Chan, Yuanxi Dai, Yijia Su
Theoretical and Natural Science (2023) Vol. 15, Iss. 1, pp. 77-86
Closed Access
A narrative review of treatment modalities for familial hypercholesterolemia
Georgios Samprokatsidis, Christina Antza, Despoina Frangou, et al.
Journal of Atherosclerosis Prevention and Treatment (2023) Vol. 14, Iss. 3, pp. 128-137
Open Access
Lipidsenkung: neue Substanzen und neue Konzepte
Julia Brandts, Marlo Verket, Dirk Müller‐Wieland
Herz (2022) Vol. 47, Iss. 5, pp. 419-425
Closed Access
Page 1

Scroll to top